BioSpace News Archive

According to the report, the global pericardiocentesis procedures market was valued at ~US$ 161 Mn in 2018 and is projected to expand at a high CAGR during the forecast period.

According to the report, the global polypill products market was valued at US$ 29.7 Bn in 2018 and is projected to expand at a CAGR of ~2% from 2019 to 2027.

According to the report, the global recombinant factor C assay market was valued at ~US$ 13 Mn in 2018 and is projected to expand at a considerable CAGR during the forecast period.

According to the report, the global medical talent management IT market was valued at US$ 991.8 Mn in 2019 and is projected to expand at a CAGR of ~10% from 2020 to 2030.

According to the report, the global customized procedure trays market was valued at ~US$ 2 Bn in 2018 and is projected to expand at a high CAGR during the forecast period.

Cathepsin B is an important mediator of inflammation and programmed cell death in individual cells. It has a role in inducing cell dissolution and recycling of cellular organelles.

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system diseases, announced that it has exceeded its enrollment target for the ANAVEX®2-73 Phase 2b/3 study in Alzheimer’s disease.

Positive Scientific Opinion Under Early Access to Medicines Scheme (EAMS) Recognizes High Unmet Medical Need in ERT Treated Late-Onset Pompe Disease Patients

Umoja Biopharma, a leading oncology company leveraging its proprietary, integrated technologies to reprogram immune cells directly in the human body to create next-generation immunotherapies for the treatment of solid tumors and hematologic malignancies, announced the appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer.

Innoforce Pharmaceuticals, an innovation and partnership-focused biopharmaceutical company, announces that the company is participating in the BIO International Digital Convention being held from June 10-18, 2021.